SFNEP oncology nutrition guidelines: When and how to assess the nutritional status? How to diagnose undernutrition and severe undernutrition? Which situations are most at risk for undernutrition?;Nutrition chez le patient adulte atteint de cancer: Quand et comment évaluer l'état nutritionnel d'un malade atteint de cancer? Comment faire le diagnostic de dénutrition et le diagnostic de dénutrition sévère chez un malade atteint de canc

Nutrition Clinique et Metabolisme

Volumn 26, Issue 4, 2012, Pages 165-188

  Senesse, Pierre ^a   Vasson, Marie Paule ^b  

^a CENTRE VAL D AURELLE   (France)

^b CRLCC Jean Perrin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIETARY INTAKE; DISEASE SEVERITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; NUTRITIONAL STATUS; PRACTICE GUIDELINE; RISK FACTOR;

EID: 84870743894     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2012.10.004     Document Type: Article

References (117)

1. Waitzberg D.L., Caiaffa W.T., Correia M.I. Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients. Nutrition 2001, 17:573-580.
2. Kruizenga H.M., Wierdsma N.J., Van Bokhorst-De Van Der Schueren M.A.E., Hollander H.J., Jonkers-Schuitema C.F., Van Der Heijden E., et al. Screening of nutritional status in The Netherlands. Clin Nutr 2003, 22:147-152.
3. Pirlich M., Schütz T., Norman K., Gastell S., Lübke H.J., Bischoff S.C., et al. The German hospital malnutrition study. Clin Nutr 2006, 25:563-572.
4. Meijers J.M.M., Schols J.M.G.A., Van Bokhorst-De Van Der Schueren M.A.E., Dassen T., Janssen M.A.P., Halfens R.J.G. Malnutrition prevalence in The Netherlands: results of the annual dutch national prevalence measurement of care problems. Br J Nutr 2009, 101:417-423.
5. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980, 69:491-497.
6. Kelsen D.P., Ginsberg R., Pajak T.F., Sheahan D.G., Gunderson L., Mortimer J., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998, 339:1979-1984.
7. Longo W.E., Virgo K.S., Johnson F.E., Oprian C.A., Vernava A.M., Wade T.P., et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 2000, 43:83-91.
8. Pessaux P., Msika S., Atalla D., Hay J.M., Flamant Y. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery. Arch Surg 2003, 138:314-324.
9. Schwartz S.R., Yueh B., Maynard C., Daley J., Henderson W., Khuri S.F. Predictors of wound complications after laryngectomy: a study of over 2000 patients. Otolaryngol Head Neck Surg 2004, 131:61-68.
10. Alves A., Panis Y., Mathieu P., Mantion G., Kwiatkowski F., Slim K. Postoperative mortality and morbidity in french patients undergoing colorectal surgery. Arch Surg 2005, 140:278-283.
11. Hollenbeck B.K., Miller D.C., Taub D., Dunn R.L., Khuri S.F., Henderson W.G., et al. Risk factors for adverse outcomes after transurethral resection of bladder tumors. Cancer 2006, 106:1527-1535.
12. Antoun S., Rey A., Béal J., Montange F., Pressoir M., Vasson M.P., et al. Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used?. World J Surg 2009, 33:1633-1640.
13. Lanzotti V.J., Thomas D.R., Boyle L.E., Smith T.L., Gehan E.A., Samuels M.L. Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria. Cancer 1977, 39:303-313.
14. Lavin P., Mittelman A., Douglass J.R.H., Engstrom P.M.D., Klaassen D. Survival and response to chemotherapy for advanced colorectal adenocarcinoma. Cancer 1980, 46:1536-1543.
15. Souhami R.L., Bradbury I., Geddes D.M., Spiro S.G., Harper P.G., Tobias J.S. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res 1985, 45:2878-2882.
16. Finkelstein D.M., Ettinger D.S., Ruckdeschel J.C. Long-term survivors in metastatic non-small-cell lung cancer: an eastern cooperative oncology groupstudy. J Clin Oncol 1986, 4:702-709.
17. Roussel A., Bleiberg H., Dalesio O., Jacob J.H., Haegele P., Jung G.M., et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys 1988, 16:67-72.
18. Allum W.H., Hallissey M.T., Kelly K.A. Adjuvant chemotherapy in operable gastric cancer. Lancet 1989, 18:571-574.
19. Kemeny N., Niedzwiecki D., Shurgot B., Oderman P. Prognostic variables in patients with hepatic metastases from colorectal cancer importance of medical assessment of liver involvement. Cancer 1989, 63:742-747.
20. Wolf M., Holle R., Hans K., Drings P., Havemann K. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 1991, 63:986-992.
21. Schaake-Koning C., Van Den Bogaert W., Dalesio O., Festen J., Hoogenhout J., Van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992, 326:524-530.
22. Jeremic B., Shibamoto Y. Pre-treatment prognostic factors in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy. Lung Cancer 1995, 13:21-30.
23. Komaki R., Scott C., Lee J.S., Urtasun R.C., Byhardt R.W., Emami B., et al. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. Am J Clin Oncol 1997, 20:435-440.
24. Scott C., Sause W.T., Byhardt R., Marcial V., Pajak T.F., Herskovic A., et al. Recursive partitioning analysis of 1592 patients on four radiation therapy oncology group studies in inoperable non-small cell lung cancer. Lung Cancer 1997, 17:S59-S74.
25. Andreyev H.J., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998, 34:503-509.
26. Cunningham D., Pyrhönen S., James R.D., Punt C.J.A., Hickish T.F., Heikkila R., et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998, 352:1413-1418.
27. Herndon J.E., Green M.R., Chahinian A.P., Corson J.M., Suzuki Y., Vogelzang N.J. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia group B. Chest 1998, 113:723-731.
28. Federico M., Vitolo U., Zinzani P.L., Chisesi T., Clò V., Bellesi G., et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood 2000, 95:783-789.
29. Vigano A., Bruera E., Jhangri G.S., Newman S.C., Fields A.L., Almazor M.E. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000, 160:861-868.
30. Buccheri G., Ferrigno D. Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 2001, 34:433-440.
31. Polee M.B., Hop W.C., Kok T.C., Eskens F.A., van der Burg M.E., Splinter T.A., et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer 2003, 89(11):2045-2050.
32. Bremnes R.M., Sundstrom S., Aasebø U., Kaasa S., Hatlevoll R., Aamdal S. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5-year follow-up. Lung Cancer 2003, 39:303-313.
33. Mitry E., Douillard J.Y., Van Cutsem E., Cunningham D., Magherini E., Mery-Mignard D., et al. Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. Ann Oncol 2004, 15:1013-1017.
34. Ross P.J., Ashley S., Norton A., Priest K., Waters J.S., Eisen T., et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer 2004, 90:1905-1911.
35. Socinski M.A., Zhang C., Herndon I.I., Dillman J.E., Clamon R.O., Vokes G., et al. Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. Ann Oncol 2004, 15:1033-1041.
36. Comella P., Massidda B., Filippelli G., Natale D., Farris A., Buzzi F., et al. Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials. Clin Colorectal Cancer 2005, 5:203-210.
37. Wakelee H.A., Wang W., Schiller J.H., Langer C.J., Sandler A.B., Belani C.P., et al. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol 2006, 1:441-446.
38. Deans D.A.C., Wigmore S.J., de Beaux A.C., Paterson-Brown S., Garden O.J., Fearon K.C.H. Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. Br J Surg 2007, 94:1501-1508.
39. Vokes E.E., Herndon J.E., Kelley M.J., Cicchetti M.G., Ramnath N., Neill H., et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: cancer and leukemia group B. J Clin Oncol 2007, 25:1698-1704.
40. Albain K.S., Swann R.S., Rusch V.W., Turrisi A.T., Shepherd F.A., Smith C., et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009, 374:379-386.
41. Martin L., Watanabe S., Fainsinger R., Lau F., Ghosh S., Quan H., et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 2010, 28:4376-4383.
42. Pressoir M., Desné S., Berchery D., Rossignol G., Poiree B., Meslier M., et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 2010, 102:966-971.
43. Sungertekin H., Sungertekin U., Balci C., Zencir M., Erdem E. The influence of nutritional status on complications after major intraabdominal surgery. J Am Coll Nutr 2004, 23:227-232.
44. Lecleire S., Di Fiore F., Antonietti M., Ben Soussan E., Hellot M.F., Grigioni S., et al. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc 2006, 64:479-484.
45. Liu S.A., Tsai W.C., Wong Y.K., Lin J.C., Poon C.K., Chao S.Y., et al. Nutritional factors and survival of patients with oral cancer. Head Neck 2006, 28:998-1007.
46. Pacelli F., Bossola M., Rosa F., Tortorelli A.P., Papa V., Doglietto G.B. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?. Clin Nutr 2008, 27:398-407.
47. Beghetto M.G., Luft V.C., Mello E.D., Polanczyk C.A. Accuracy of nutritional assessment tools for predicting adverse hospital outcomes. Nutr Hosp 2009, 24:56-62.
48. Wu B.W., Yin T., Cao W.X., Gu Z.D., Wang X.J., Yan M., et al. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gastroenterol 2009, 15:3542-3549.
49. Sanz Ortiz J., Moreno Nogueira J.A., García de Lorenzo, Mateos A. Protein energy malnutrition (PEM) in cancer patients. Clin Transl Oncol 2008, 10:579-582.
50. Baracos V.E., Reiman T., Mourtzakis M., Gioulbasanis I., Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010, 91:1133S-1137S.
51. Landi F., Onder G., Gambassi G., Pedone C., Carbonin P.U., Bernabei R. Body mass index and mortality among hospitalized patients. Arch Intern Med 2000, 160:2641-2644.
52. Klein S., Kinney J., Jeejeebhoy K., Alpers D., Hellerstein M., Murray M., et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Clin Nutr 1997, 16:193-218.
53. Duguet A., Bachmann P., Lallemand Y., Blanc-Vincent M.P. Good clinical practice in nutritional management in cancer patients: malnutrition and nutritional assessment. Bull Cancer 1999, 86:997-1016.
54. Loprinzi C.L., Laurie J.A., Wieand H.S., Krook J.E., Novotny P.J., Kugler J.W., et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 1994, 12:601-607.
55. Kubrak C., Olson K., Jha N., Jensen L., McCargar L., Seikaly H., et al. Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck 2010, 32:290-300.
56. Bozzetti F., SCRINIO Working Group Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 2009, 17:279-284.
57. Thibault R., Goujon N., Le Gallic E., Clairand R., Sébille V., Vibert J., et al. Use of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk. Clin Nutr 2009, 28:134-140.
58. Deans D.A., Tan B.H., Wigmore S.J., Ross J.A., de Beaux A.C., Paterson-Brown S., et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009, 100:63-69.
59. Poon R.T., Fan S.T., Lo C.M., Liu C.L., Lam C.M., Yuen W.K., et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004, 240:698-708.
60. Bozzetti F., Gianotti L., Braga M., Di Carlo V., Mariani L. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 2007, 26:698-709.
61. Gibbs J., Cull W., Henderson W., Daley J., Hur K., Khuri S.F. Preoperative serum albumin level as a predictor of operative mortality and morbidity. Arch Surg 1999, 134:36-42.
62. Swenerton K.D., Legha S.S., Smith T., Hortobagyi G.N., Gehan E.A., Yap H.Y., et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979, 39:1552-1562.
63. Sirott M.N., Bajorin D.F., Wong G.Y.C., Tao Y., Chapman P.B., Templeton M.A., et al. Prognostic factors in patients with metastatic malignant melanoma. Cancer 1993, 72:3091-3098.
64. Wyld L., Gutteridge E., Pinder S.E., James J.J., Chan S.Y., Cheung K.L., et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003, 89:284-290.
65. Seve P., Ray-Coquard I., Trillet-Lenoir V., Sawyer M., Hanson J., Broussolle C., et al. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer 2006, 107:2698-2705.
66. Salas S., Deville J.L., Giorgi R., Pignon T., Bagarry D., Barrau K., et al. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiother Oncol 2008, 87:195-200.
67. Gioulbasanis I., Baracos V.E., Giannousi Z., Xyrafas A., Martin L., Georgoulias V., et al. Baseline nutritional evaluation in metastatic lung cancer patients: mini nutritional assessment versus weight loss history. Ann Oncol 2011, 22:835-841.
68. Goransson J., Jonssont S., Lasson A. Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery. Eur J Surg Oncol 1996, 22:607-617.
69. McMillan D.C., Elahi M.M., Sattar N., Angerson W.J., Johnstone J., McArdle C.S. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001, 41:64-69.
70. Ikeda M., Natsugoe S., Ueno S., Baba M., Aikou T. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 2003, 238:197-202.
71. Marsik C., Kazemi-Shirazi L., Schickbauer T., Winkler S., Joukhadar C., Wagner O.F., et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008, 54:343-349.
72. Crumley A.B., Stuart R.C., McKernan M., McMillan D.C. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?. World J Surg 2010, 34:2393-2398.
73. Nguyen X.M., Lane J., Smith B.R., Nguyen N.T. Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J Gastrointest Surg 2009, 13:1205-1212.
74. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991, 325:525-532.
75. Buzby G.P., Knox L.S., Crosby L.O., Eisenberg J.M., Haakenson C.M., McNeal G.E., et al. Study protocol: a randomized clinical trial of total parenteral nutrition inmalnourished surgical patients. Am J Clin Nutr 1988, 47:366-381.
76. Baker J.P., Detsky A.S., Wesson D.E., Wolman S.L., Stewart S., Whitewell J., et al. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982, 306:969-972.
77. Ottery F.D. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996, 12:S15-S19.
78. Ferguson M., Capra S., Bauer J., Banks M. Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition 1999, 15:458-464.
79. Stratton R.J., Hackston A., Longmore D., Dixon R., Price S., Stroud M., et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'malnutrition universal screening tool' ('MUST') for adults. Br J Nutr 2004, 92:799-808.
80. Guigoz Y., Vellas B., Garry P.J. Mini-nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts Res Gerontol 1994, 4(Suppl. 2):15-59.
81. Kondrup J., Rasmussen H.H., Hamberg O., Stanga Z., Ad Hoc ESPEN Working Group Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003, 22:321-336.
82. Forrest L.M., McMillan D.C., McArdle C.S., Angerson W.J., Dunlop D.J. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003, 89:1028-1030.
83. Leitch E.F., Chakrabarti M., Crozier J.E., McKee R.F., Anderson J.H., Horgan P.G., et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 2007, 97(9):1266-1270.
84. Rey-Ferro M., Castaño R., Orozco O., Serna A., Moreno A. Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. Nutrition 1997, 13(10):878-881.
85. Schiesser M., Müller S., Kirchhoff P., Breitenstein S., Schäfer M., Clavien P.A. Assessment of a novel screening score for nutritional risk in predicting complications in gastro-intestinal surgery. Clin Nutr 2008, 27(4):565-570.
86. Guo W., Ou G., Li X., Huang J., Liu J., Wei H. Screening of the nutritional risk of patients with gastric carcinoma before operation by NRS 2002 and its relationship with postoperative results. J Gastroenterol Hepatol 2010, 25(4):800-803.
87. Laky B., Janda M., Kondalsamy-Chennakesavan S., Cleghorn G., Obermair A. Pretreatment malnutrition and quality of life-association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer 2010, 10:232.
88. Persson C., Sjödén P.O., Glimelius B. The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers. Clin Nutr 1999, 18:71-77.
89. Bauer J., Capra S., Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002, 56(8):779-785.
90. Isenring E., Bauer J., Capra S. The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 2003, 57(2):305-309.
91. Gupta D., Lammersfeld C.A., Vashi P.G., Burrows J., Lis C.G., Grutsch J.F. Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 2005, 59(1):35-40.
92. Wakahara T., Shiraki M., Murase K., Fukushima H., Matsuura K., Fukao A., et al. Nutritional screening with Subjective Global Assessment predicts hospital stay in patients with digestive diseases. Nutrition 2007, 23(9):634-639.
93. Amaral T.F., Antunes A., Cabral S., Alves P., Kent-Smith L. An evaluation of three nutritional screening tools in a Portuguese oncology centre. J Hum Nutr Diet 2008, 21:575-583.
94. Gupta D., Lammersfeld C.A., Vashi P.G., Dahlk S.L., Lis C.G. Can subjective global assessment of nutritional status predict survival in ovarian cancer?. J Ovarian Res 2008, 1(1):5.
95. Aaldriks A.A., Maartense E., le Cessie S., Giltay E.J., Verlaan H.A., van der Geest L.G., et al. Predictive value of geriatric assessment for patients older than 70years, treated with chemotherapy. Crit Rev Oncol Hematol 2011, 79(2):205-212.
96. Schneider S.M., Veyres P., Pivot X., Soummer A.M., Jambou P., Filippi J., et al. Malnutrition is an independent factor associated with nosocomial infections. Br J Nutr 2004, 92:105-111.
97. Kyle U.G., Schneider S.M., Pirlich M., Lochs H., Hebuterne X., Pichard C. Does nutritional risk, as assessed by Nutritional Risk Index, increase during hospital stay? A multinational population-based study. Clin Nutr 2005, 24:516-524.
98. McMillan D.C. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009, 12:223-236.
99. Elahi M.M., McMillan D.C., McArdle C.S., Angerson W.J., Sattar N. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 2004, 48(2):171-173.
100. Murri A.M., Bartlett J.M., Canney P.A., Doughty J.C., Wilson C., McMillan D.C. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 2006, 94(2):227-230.
101. Sharma R., Hook J., Kumar M., Gabra H. Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 2008, 44(2):251-256.
102. McMillan D.C., Crozier J.E., Canna K., Angerson W.J., McArdle C.S. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007, 22(8):881-886.
103. Moyes L.H., Leitch E.F., McKee R.F., Anderson J.H., Horgan P.G., McMillan D.C. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 2009, 100(8):1236-1239.
104. Ishizuka M., Nagata H., Takagi K., Kubota K. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg 2009, 250(2):268-272.
105. Laky B., Janda M., Cleghorn G., Obermair A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 2008, 87:1678-1685.
106. Ferguson M.L., Bauer J., Gallagher B., Capra S., Christie D.R., Mason B.R. Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol 1999, 43:325-327.
107. Isenring E., Cross G., Daniels L., Kellett E., Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer 2006, 14:1152-1156.
108. Bauer J., Capra S. Comparison of a malnutrition screening tool with subjective global assessment in hospitalised patients with cancer-sensitivity and specificity. Asia Pac J Clin Nutr 2003, 12:257-260.
109. Read J.A., Crockett N., Volker D.H., MacLennan P., Choy S.T., Beale P., et al. Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PG-SGA). Nutr Cancer 2005, 53:51-56.
110. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629-635.
111. Prado C.M., Baracos V.E., McCargar L.J., Mourtzakis M., Mulder K.E., Reiman T., et al. Body composition as an independent determinant of 5-fluorouracil-basedchemotherapy toxicity. Clin Cancer Res 2007, 13:3264-3268.
112. Prado C.M., Baracos V.E., McCargar L.J., Reiman T., Mourtzakis M., Tonkin K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009, 15:2920-2926.
113. Antoun S., Baracos V.E., Birdsell L., Escudier B., Sawyer M.B. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 2010, 21:1594-1598.
114. Guiu B., Petit J.M., Bonnetain F., Ladoire S., Guiu S., Cercueil J.P., et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 2010, 59:341-347.
115. Tan B.H., Birdsell L.A., Martin L., Baracos V.E., Fearon K.C. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009, 15:6973-6979.
116. Stanga Z., Brunner A., Leuenberger M., Grimble R.F., Shenkin A., Allison S.P., et al. Nutrition in clinical practice-the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr 2008, 62:687-694.
117. Boateng A.A., Sriram K., Meguid M.M., Crook M. Refeeding syndrome: treatment considerations based on collective analysis of literature case reports. Nutrition 2010, 26:156-167.